13C-breath tests: Current state of the art and future directions

Digestive and Liver Disease

Volumn 39, Issue 9, 2007, Pages 795-805

  Braden, B ^a,b   Lembcke, B ^c   Kuker, W ^a   Caspary, W F ^b  

^a JOHN RADCLIFFE HOSPITAL   (United Kingdom)

^b UNIVERSITY HOSPITAL FRANKFURT   (Germany)

^c St Barbara Hospital   (Germany)

Author keywords

Gastric emptying; Helicobacter pylori; Liver function; Stable isotopes

Indexed keywords

ACETIC ACID; CARBON 13; OCTANOIC ACID; PANCREAS ENZYME; CARBON;

BACTERIAL GROWTH; BACTERIUM DETECTION; CARBOHYDRATE ANALYSIS; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; ENZYME ACTIVITY; ENZYME ANALYSIS; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HUMAN; INFRARED SPECTROMETRY; INTERMETHOD COMPARISON; INTESTINE TRANSIT TIME; ISOTOPE LABELING; LIVER FUNCTION TEST; LIVER METABOLISM; MALABSORPTION; MASS SPECTROMETRY; NON INVASIVE PROCEDURE; NONHUMAN; PANCREAS FUNCTION TEST; PANCREAS INSUFFICIENCY; PRACTICE GUIDELINE; QUANTITATIVE ANALYSIS; RELIABILITY; SCINTIGRAPHY; SENSITIVITY AND SPECIFICITY; SHORT SURVEY; STOMACH EMPTYING; UREA BREATH TEST; BREATH ANALYSIS; GASTROINTESTINAL DISEASE; METABOLISM; METHODOLOGY; PANCREAS; PHYSIOLOGY; REVIEW;

BREATH TESTS; CARBON ISOTOPES; GASTRIC EMPTYING; GASTROINTESTINAL DISEASES; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; LIVER FUNCTION TESTS; PANCREAS, EXOCRINE;

EID: 34547650941     PISSN: 15908658     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.dld.2007.06.012     Document Type: Short Survey

References (142)

1. Adamek R.J., Goetze O., Boedeker C., Pfaffenbach B., Luypaerts A., and Geypens B. 13C-methacetin breath test: isotope-selective nondispersive infrared spectrometry in comparison to isotope ratio mass spectrometry in volunteers and patients with liver cirrhosis. Z Gastroenterol 37 (1999) 1139-1143
2. 2-abundance in breath samples with a new isotope selective-nondispersive infrared spectrometer. Z Gastroenterol 32 (1994) 675-678
3. Pfaffenbach B., Gotze O., Szymanski C., Hagemann D., and Adamek R.J. The 13C-methacetin breath test for quantitative noninvasive liver function analysis with an isotope-specific nondispersive infrared spectrometer in liver cirrhosis. Dtsch Med Wochenschr 123 (1998) 1467-1471
4. Savarino V., Mela G.S., Zentilin P., Bisso G., Pivari M., Mansi C., et al. Comparison of isotope ratio mass spectrometry and nondispersive isotope-selective infrared spectroscopy for 13C-urea breath test. Am J Gastroenterol 94 (1999) 1203-1208
5. Graham D.Y., Klein P.D., Evans Jr. D.J., Evans D.G., Alpert L.C., Opekun A.R., et al. Campylobacter pylori detected noninvasively by the 13C-urea breath test. Lancet 1 (1987) 1174-1177
6. Gatta L., Ricci C., Tampieri A., Osborn J., Perna F., Bernabucci V., et al. Accuracy of breath tests using low doses of 13C-urea to diagnose Helicobacter pylori infection: a randomised controlled trial. Gut (2005)
7. Braden B., Duan L.P., Caspary W.F., and Lembcke B. More convenient 13C-urea breath test modifications still meet the criteria for valid diagnosis of Helicobacter pylori infection. Z Gastroenterol 32 (1994) 198-202
8. Klein P.D., Malaty H.M., Martin R.F., Graham K.S., Genta R.M., and Graham D.Y. Noninvasive detection of Helicobacter pylori infection in clinical practice: the 13C urea breath test. Am J Gastroenterol 91 (1996) 690-694
9. Graham D.Y., Malaty H.M., Cole R.A., Martin R.F., and Klein P.D. Simplified 13C-urea breath test for detection of Helicobacter pylori infection. Am J Gastroenterol 96 (2001) 1741-1745
10. Leodolter A., Dominguez-Munoz J.E., von Arnim U., Kahl S., Peitz U., and Malfertheiner P. Validity of a modified 13C-urea breath test for pre- and posttreatment diagnosis of Helicobacter pylori infection in the routine clinical setting. Am J Gastroenterol 94 (1999) 2100-2104
11. Klein P.D., and Graham D.Y. Minimum analysis requirements for the detection of Helicobacter pylori infection by the 13C-urea breath test. Am J Gastroenterol 88 (1993) 1865-1869
12. Vaira D., and Vakil N. Blood, urine, stool, breath, money, and Helicobacter pylori. Gut 48 (2001) 287-289
13. Malfertheiner P., Megraud F., O'Morain C., Hungin A.P., Jones R., Axon A., et al. Current concepts in the management of Helicobacter pylori infection-the Maastricht 2-2000 Consensus Report. Aliment Pharmacol Ther 16 (2002) 167-180
14. Braden B., Teuber G., Dietrich C.F., Caspary W.F., and Lembcke B. Comparison of new faecal antigen test with (13)C-urea breath test for detecting Helicobacter pylori infection and monitoring eradication treatment: prospective clinical evaluation. Br Med J 320 (2000) 148
15. Maes B.D., Geypens B.J., Ghoos Y.F., Hiele M.I., and Rutgeerts P.J. 13C-Octanoic acid breath test for gastric emptying rate of solids. Gastroenterology 114 (1998) 856-859
16. Duan L.P., Braden B., Caspary W.F., and Lembcke B. Influence of cisapride on gastric emptying of solids and liquids monitored by 13C breath tests. Dig Dis Sci 40 (1995) 2200-2206
17. Van Den Driessche M., Peeters K., Marien P., Ghoos Y., Devlieger H., and Veereman-Wauters G. Gastric emptying in formula-fed and breast-fed infants measured with the 13C-octanoic acid breath test. J Pediatr Gastroenterol Nutr 29 (1999) 46-51
18. Choi M.G., Camilleri M., Burton D.D., Zinsmeister A.R., Forstrom L.A., and Nair K.S. Reproducibility and simplification of 13C-octanoic acid breath test for gastric emptying of solids. Am J Gastroenterol 93 (1998) 92-98
19. Choi M.G., Camilleri M., Burton D.D., Zinsmeister A.R., Forstrom L.A., and Nair K.S. [13C]octanoic acid breath test for gastric emptying of solids: accuracy, reproducibility, and comparison with scintigraphy. Gastroenterology 112 (1997) 1155-1162
20. Bromer M.Q., Kantor S.B., Wagner D.A., Knight L.C., Maurer A.H., and Parkman H.P. Simultaneous measurement of gastric emptying with a simple muffin meal using [13C]octanoate breath test and scintigraphy in normal subjects and patients with dyspeptic symptoms. Dig Dis Sci 47 (2002) 1657-1663
21. Barnett C., Snel A., Omari T., Davidson G., Haslam R., and Butler R. Reproducibility of the 13C-octanoic acid breath test for assessment of gastric emptying in healthy preterm infants. J Pediatr Gastroenterol Nutr 29 (1999) 26-30
22. Ziegler D., Schadewaldt P., Pour Mirza A., Piolot R., Schommartz B., Reinhardt M., et al. [13C]octanoic acid breath test for non-invasive assessment of gastric emptying in diabetic patients: validation and relationship to gastric symptoms and cardiovascular autonomic function. Diabetologia 39 (1996) 823-830
23. Maes B.D., Ghoos Y.F., Rutgeerts P.J., Hiele M.I., Geypens B., and Vantrappen G. [*C]octanoic acid breath test to measure gastric emptying rate of solids. Dig Dis Sci 39 12 Suppl. (1994) 104S-106S
24. Braden B., Adams S., Duan L.P., Orth K.H., Maul F.D., Lembcke B., et al. The [13C]acetate breath test accurately reflects gastric emptying of liquids in both liquid and semisolid test meals. Gastroenterology 108 (1995) 1048-1055
25. Maes B.D., Ghoos Y.F., Geypens B.J., Mys G., Hiele M.I., Rutgeerts P.J., et al. Combined carbon-13-glycine/carbon-14-octanoic acid breath test to monitor gastric emptying rates of liquids and solids. J Nucl Med 35 (1994) 824-831
26. Giannini E., Fasoli A., Chiarbonello B., Malfatti F., Romagnoli P., Botta F., et al. 13C-aminopyrine breath test to evaluate severity of disease in patients with chronic hepatitis C virus infection. Aliment Pharmacol Ther 16 (2002) 717-725
27. Irving C.S., Schoeller D.A., Nakamura K.I., Baker A.L., and Klein P.D. The aminopyrine breath test as a measure of liver function. A quantitative description of its metabolic basis in normal subjects. J Lab Clin Med 100 (1982) 356-373
28. Mion F., Queneau P.E., Rousseau M., Brazier J.L., Paliard P., and Minaire Y. Aminopyrine breath test: development of a 13C-breath test for quantitative assessment of liver function in humans. Hepatogastroenterology 42 (1995) 931-938
29. 2 excretion in breath of normal subjects and cirrhotic patients after 13C-aminopyrine oral load. Comparison with MEGX test in functional differentiation between chronic hepatitis and liver cirrhosis. Hepatogastroenterology 47 (2000) 234-238
30. Festi D., Capodicasa S., Sandri L., Colaiocco-Ferrante L., Staniscia T., Vitacolonna E., et al. Measurement of hepatic functional mass by means of 13C-methacetin and 13C-phenylalanine breath tests in chronic liver disease: comparison with Child-Pugh score and serum bile acid levels. World J Gastroenterol 11 (2005) 142-148
31. Braden B., Faust D., Sarrazin U., Zeuzem S., Dietrich C.F., Caspary W.F., et al. 13C-methacetin breath test as liver function test in patients with chronic hepatitis C virus infection. Aliment Pharmacol Ther 21 (2005) 179-185
32. Schneider A., Caspary W.F., Saich R., Dietrich C.F., Sarrazin C., Kuker W., et al. 13C-methacetin breath test shortened: 2-point-measurements after 15 minutes reliably indicate the presence of liver cirrhosis. J Clin Gastroenterol 41 (2007) 33-37
33. Mion F., Rousseau M., Scoazec J.Y., Berger F., and Minaire Y. [13C]-Galactose breath test: correlation with liver fibrosis in chronic hepatitis C. Eur J Clin Invest 29 (1999) 624-629
34. Giannini E.G., Fasoli A., Borro P., Botta F., Malfatti F., Fumagalli A., et al. 13C-galactose breath test and 13C-aminopyrine breath test for the study of liver function in chronic liver disease. Clin Gastroenterol Hepatol 3 (2005) 279-285
35. Mion F., Geloen A., and Minaire Y. Effects of ethanol and diabetes on galactose oxidative metabolism and elimination in rats. Can J Physiol Pharmacol 77 (1999) 182-187
36. Mion F., Rousseau M., Brazier J.L., and Minaire Y. Human hepatic macrovesicular steatosis: a noninvasive study of mitochondrial ketoisocaproic acid decarboxylation. Metabolism 44 (1995) 699-700
37. Lauterburg B.H., Grattagliano I., Gmur R., Stalder M., and Hildebrand P. Noninvasive assessment of the effect of xenobiotics on mitochondrial function in human beings: studies with acetylsalicylic acid and ethanol with the use of the carbon 13-labeled ketoisocaproate breath test. J Lab Clin Med 125 (1995) 378-383
38. Witschi A., Mossi S., Meyer B., Junker E., and Lauterburg B.H. Mitochondrial function reflected by the decarboxylation of [13C]ketoisocaproate is impaired in alcoholics. Alcohol Clin Exp Res 18 (1994) 951-955
39. Armuzzi A., Marcoccia S., Zocco M.A., De Lorenzo A., Grieco A., Tondi P., et al. Non-Invasive assessment of human hepatic mitochondrial function through the 13C-methionine breath test. Scand J Gastroenterol 35 (2000) 650-653
40. Banasch M., Goetze O., and Susanne K. Response to 13C-methionine breath test detects drug-related hepatic mitochondrial dysfunction in HIV-infected patients. J Acquir Immune Defic Syndr 41 (2006) 253-254
41. Banasch M., Goetze O., Hollborn I., Hochdorfer B., Bulut K., Schlottmann R., et al. 13C-methionine breath test detects distinct hepatic mitochondrial dysfunction in HIV-infected patients with normal serum lactate. J Acquir Immune Defic Syndr 40 (2005) 149-154
42. Di Campli C., Angelini G., Armuzzi A., Nardo B., Zocco M.A., Candelli M., et al. Quantitative evaluation of liver function by the methionine and aminopyrine breath tests in the early stages of liver transplantation. Eur J Gastroenterol Hepatol 15 (2003) 727-732
43. Ishii Y., Asai S., Kohno T., Takahashi Y., Nagata T., Suzuki S., et al. Evaluation of liver regeneration using the L-[1-13C]methionine breath test. J Surg Res 95 (2001) 195-199
44. Degre D., Bourgeois N., Boon N., Le Moine O., Louis H., Donckier V., et al. Aminopyrine breath test compared to the MELD and Child-Pugh scores for predicting mortality among cirrhotic patients awaiting liver transplantation. Transpl Int 17 (2004) 31-38
45. Caubet M.S., Laplante A., Caille J., and Brazier J.L. [13C]aminopyrine and [13C]caffeine breath test: influence of gender, cigarette smoking and oral contraceptives intake. Isotopes Environ Health Stud 38 (2002) 71-77
46. Opekun Jr. A.R., Klein P.D., and Graham D.Y. [13C]Aminopyrine breath test detects altered liver metabolism caused by low-dose oral contraceptives. Dig Dis Sci 40 (1995) 2417-2422
47. 2 exhalation test. Investigation with an isotope selective, non dispersive infrared spectrophotometer of indirect function of the exocrine pancreas. Dtsch Med Wochenschr 124 (1999) 103-108
48. Vantrappen G.R., Rutgeerts P.J., Ghoos Y.F., and Hiele M.I. Mixed triglyceride breath test: a noninvasive test of pancreatic lipase activity in the duodenum. Gastroenterology 96 (1989) 1126-1134
49. van Dijk-van Aalst K., Van Den Driessche M., van Der Schoor S., Schiffelers S., van't Westeinde T., Ghoos Y., et al. 13C mixed triglyceride breath test: a noninvasive method to assess lipase activity in children. J Pediatr Gastroenterol Nutr 32 (2001) 579-585
50. Boedeker C., Goetze O., Pfaffenbach B., Luypaerts A., Geypens B., and Adamek R.J. 13C mixed-triglyceride breath test: isotope selective non-dispersive infrared spectrometry in comparison with isotope ratio mass spectrometry in volunteers and patients with chronic pancreatitis. Scand J Gastroenterol 34 (1999) 1153-1156
51. Perri F., Pastore M., Festa V., Clemente R., Quitadamo M., D'Altilia M.R., et al. Intraduodenal lipase activity in celiac disease assessed by means of 13C mixed-triglyceride breath test. J Pediatr Gastroenterol Nutr 27 (1998) 407-410
52. Loser C., Brauer C., Aygen S., Hennemann O., and Folsch U.R. Comparative clinical evaluation of the 13C-mixed triglyceride breath test as an indirect pancreatic function test. Scand J Gastroenterol 33 (1998) 327-334
53. Miyakawa S., Hayakawa M., Horiguchi A., Mizuno K., Ishihara S., Niwamoto N., et al. Estimation of fat absorption with the 13C-trioctanoin breath test after pancreatoduodenectomy or pancreatic head resection. World J Surg 20 (1996) 1024-1028 discussion 1028-9
54. McClean P., Harding M., Coward W.A., Green M.R., and Weaver L.T. Measurement of fat digestion in early life using a stable isotope breath test. Arch Dis Child 69 (1993) 366-370
55. Kato H., Nakao A., Kishimoto W., Nonami T., Harada A., Hayakawa T., et al. 13C-labeled trioctanoin breath test for exocrine pancreatic function test in patients after pancreatoduodenectomy. Am J Gastroenterol 88 (1993) 64-69
56. 2 breath test. Arch Dis Child 65 (1990) 574-578
57. Watkins J.B., Klein P.D., Schoeller D.A., Kirschner B.S., Park R., and Perman J.A. Diagnosis and differentiation of fat malabsorption in children using 13C-labeled lipids: trioctanoin, triolein, and palmitic acid breath tests. Gastroenterology 82 5 Pt 1 (1982) 911-917
58. Watkins J.B., Schoeller D.A., Klein P.D., Ott D.G., Newcomer A.D., and Hofmann A.F. 13C-trioctanoin: a nonradioactive breath test to detect fat malabsorption. J Lab Clin Med 90 (1977) 422-430
59. Ritz M.A., Fraser R.J., Di Matteo A.C., Greville H., Butler R., Cmielewski P., et al. Evaluation of the 13C-triolein breath test for fat malabsorption in adult patients with cystic fibrosis. J Gastroenterol Hepatol 19 (2004) 448-453
60. Bryant L.K., Fraser R.J., Vozzo R., Zacharakis B., Matthews G.M., and Butler R. Stimulation of small intestinal burst activity in the postprandial state differentially affects lipid and glucose absorption in healthy adult humans. Am J Physiol Gastrointest Liver Physiol 287 (2004) G1028-G1034
61. Wutzke K.D., Radke M., Breuel K., Gurk S., Lafrenz J.D., and Heine W.E. Triglyceride oxidation in cystic fibrosis: a comparison between different 13C-labeled tracer substances. J Pediatr Gastroenterol Nutr 29 (1999) 148-154
62. Murphy J.L., Laiho K.M., Jones A.E., and Wootton S.A. Metabolic handling of 13C labelled tripalmitin in healthy controls and patients with cystic fibrosis. Arch Dis Child 79 (1998) 44-47
63. Lembcke B., Braden B., and Caspary W.F. Exocrine pancreatic insufficiency: accuracy and clinical value of the uniformly labelled 13C-Hiolein breath test. Gut 39 (1996) 668-674
64. Sun D.Y., Jiang Y.B., Rong L., Jin S.J., and Xie W.Z. Clinical application of 13C-Hiolein breath test in assessing pancreatic exocrine insufficiency. Hepatobiliary Pancreat Dis Int 2 (2003) 449-452
65. Cole S.G., Rossi S., Stern A., and Hofmann A.F. Cholesteryl octanoate breath test. Preliminary studies on a new noninvasive test of human pancreatic exocrine function. Gastroenterology 93 (1987) 1372-1380
66. Ventrucci M., Cipolla A., Ubalducci G.M., Roda A., and Roda E. 13C labelled cholesteryl octanoate breath test for assessing pancreatic exocrine insufficiency. Gut 42 (1998) 81-87
67. Mundlos S., Kuhnelt P., and Adler G. Monitoring enzyme replacement treatment in exocrine pancreatic insufficiency using the cholesteryl octanoate breath test. Gut 31 (1990) 1324-1328
68. Jonderko K., Kasicka-Jonderko A., Syrkiewicz-Trepiak D., and Blonska-Fajfrowska B. Feasibility of a breath test with a substrate of natural 13C-abundance and isotope-selective non-dispersive infrared spectrometry: a preliminary study. J Gastroenterol Hepatol 20 (2005) 1228-1234
69. Amarri S., Harding M., Coward W.A., Evans T.J., and Weaver L.T. 13C and H2 breath tests to study extent and site of starch digestion in children with cystic fibrosis. J Pediatr Gastroenterol Nutr 29 (1999) 327-331
70. Loser C., Mollgaard A., Aygen S., Hennemann O., and Folsch U.R. 13C-starch breath test-comparative clinical evaluation of an indirect pancreatic function test. Z Gastroenterol 35 (1997) 187-194
71. Dewit O., Prentice A., Coward W.A., and Weaver L.T. Starch digestion in young children with cystic fibrosis measured using a 13C breath test. Pediatr Res 32 (1992) 45-49
72. 2 breath test. Gastroenterology 96 2 Pt 1 (1989) 503-509
73. Evenepoel P., Hiele M., Geypens B., Geboes K.P., Rutgeerts P., and Ghoos Y. 13C-egg white breath test: a non-invasive test of pancreatic trypsin activity in the small intestine. Gut 46 (2000) 52-57
74. Geboes K.P., Bammens B., Luypaerts A., Malheiros R., Buyse J., Evenepoel P., et al. Validation of a new test meal for a protein digestion breath test in humans. J Nutr 134 (2004) 806-810
75. Braden B., Picard H., Caspary W.F., Posselt H.G., and Lembcke B. Monitoring pancreatin supplementation in cystic fibrosis patients with the 13C-Hiolein breath test: evidence for normalized fat assimilation with high dose pancreatin therapy. Z Gastroenterol 35 (1997) 123-129
76. Solomons N.W., Schoeller D.A., Wagonfeld J.B., Ott D., Rosenberg I.H., and Klein P.D. Application of a stable isotope (13C)-labeled glycocholate breath test to diagnosis of bacterial overgrowth and ileal dysfunction. J Lab Clin Med 90 (1977) 431-439
77. Schoeller D.A., Klein P.D., MacLean Jr. W.C., Watkins J.B., and van Santen E. Fecal 13C analysis for the detection and quantitation of intestinal malabsorption. Limits of detection and application to disorders of intestinal cholylglycine metabolism. J Lab Clin Med 97 (1981) 440-448
78. Dellert S.F., Nowicki M.J., Farrell M.K., Delente J., and Heubi J.E. The 13C-xylose breath test for the diagnosis of small bowel bacterial overgrowth in children. J Pediatr Gastroenterol Nutr 25 (1997) 153-158
79. Walters B., and Vanner S.J. Detection of bacterial overgrowth in IBS using the lactulose H2 breath test: comparison with 14C-D-xylose and healthy controls. Am J Gastroenterol 100 (2005) 1566-1570
80. King C.E., and Toskes P.P. Comparison of the 1-gram [14C]xylose, 10-gram lactulose-H2, and 80-gram glucose-H2 breath tests in patients with small intestine bacterial overgrowth. Gastroenterology 91 (1986) 1447-1451
81. Morrison D.J., Dodson B., Preston T., and Weaver L.T. Gastrointestinal handling of glycosyl [13C]ureides. Eur J Clin Nutr 57 (2003) 1017-1024
82. Van Den Driessche M., Van Malderen N., Geypens B., Ghoos Y., and Veereman-Wauters G. Lactose-[13C]ureide breath test: a new, noninvasive technique to determine orocecal transit time in children. J Pediatr Gastroenterol Nutr 31 (2000) 433-438
83. Heine W.E., Berthold H.K., and Klein P.D. A novel stable isotope breath test: 13C-labeled glycosyl ureides used as noninvasive markers of intestinal transit time. Am J Gastroenterol 90 (1995) 93-98
84. Geypens B., Bennink R., Peeters M., Evenepoel P., Mortelmans L., Maes B., et al. Validation of the lactose-[13C]ureide breath test for determination of orocecal transit time by scintigraphy. J Nucl Med 40 (1999) 1451-1455
85. 2-breath test in humans. Eur J Clin Nutr 51 (1997) 11-19
86. Vonk R.J., Priebe M.G., Koetse H.A., Stellaard F., Lenoir-Wijnkoop I., Antoine J.M., et al. Lactose intolerance: analysis of underlying factors. Eur J Clin Invest 33 (2003) 70-75
87. Vonk R.J., Stellaard F., Priebe M.G., Koetse H.A., Hagedoorn R.E., De Bruijn S., et al. The 13C/2H-glucose test for determination of small intestinal lactase activity. Eur J Clin Invest 31 (2001) 226-233
88. 2 breath test using naturally 13C-enriched lactose for detection of lactase deficiency in patients with gastrointestinal symptoms. J Lab Clin Med 112 (1988) 193-200
89. Seal C.J., Daly M.E., Thomas L.C., Bal W., Birkett A.M., Jeffcoat R., et al. Postprandial carbohydrate metabolism in healthy subjects and those with type 2 diabetes fed starches with slow and rapid hydrolysis rates determined in vitro. Br J Nutr 90 (2003) 853-864
90. Robertson M.D., Livesey G., and Mathers J.C. Quantitative kinetics of glucose appearance and disposal following a 13C-labelled starch-rich meal: comparison of male and female subjects. Br J Nutr 87 (2002) 569-577
91. Weaver L.T., Dibba B., Sonko B., Bohane T.D., and Hoare S. Measurement of starch digestion of naturally 13C-enriched weaning foods, before and after partial digestion with amylase-rich flour, using a 13C breath test. Br J Nutr 74 (1995) 531-537
92. 2 breath test to measure the hydrolysis of various starch formulations in healthy subjects. Gut 31 (1990) 175-178
93. Hiele M., Ghoos Y., Rutgeerts P., and Vantrappen G. Effects of acarbose on starch hydrolysis. Study in healthy subjects, ileostomy patients, and in vitro. Dig Dis Sci 37 (1992) 1057-1064
94. 2 breath tests for the detection of fructose malabsorption. J Lab Clin Med 127 (1996) 303-309
95. 2 breath tests and isotope ratio mass spectrometry. Biomed Environ Mass Spectrom 16 (1988) 133-135
96. Mosora F., Lacroix M., Luyckx A., Pallikarakis N., Pirnay F., Krzentowski G., et al. Glucose oxidation in relation to the size of the oral glucose loading dose. Metabolism 30 (1981) 1143-1149
97. 2] recovery from an oral glucose load during exercise: comparison between [U-13C] and [1,2-13C]glucose. J Appl Physiol 95 (2003) 477-482
98. Murray R.D., Boutton T.W., Klein P.D., Gilbert M., Paule C.L., and MacLean Jr. W.C. Comparative absorption of [13C]glucose and [13C]lactose by premature infants. Am J Clin Nutr 51 (1990) 59-66
99. Wu G.H., Wu Z.H., and Wu Z.G. Effects of bowel rehabilitation and combined trophic therapy on intestinal adaptation in short bowel patients. World J Gastroenterol 9 (2003) 2601-2604
100. Jones A.E., Stolinski M., Smith R.D., Murphy J.L., and Wootton S.A. Effect of fatty acid chain length and saturation on the gastrointestinal handling and metabolic disposal of dietary fatty acids in women. Br J Nutr 81 (1999) 37-43
101. Jones A.E., Murphy J.L., Stolinski M., and Wootton S.A. The effect of age and gender on the metabolic disposal of [1-13C] palmitic acid. Eur J Clin Nutr 52 (1998) 22-28
102. Arimoto K., Sakuragawa N., Suehiro M., and Watanabe H. Abnormal 13C-fatty acid breath tests in patients treated with valproic acid. J Child Neurol 3 (1988) 250-257
103. Bammens B., Evenepoel P., Verbeke K., and Vanrenterghem Y. Impairment of small intestinal protein assimilation in patients with end-stage renal disease: extending the malnutrition-inflammation-atherosclerosis concept. Am J Clin Nutr 80 (2004) 1536-1543
104. Evenepoel P., Claus D., Geypens B., Maes B., Hiele M., Rutgeerts P., et al. Evidence for impaired assimilation and increased colonic fermentation of protein, related to gastric acid suppression therapy. Aliment Pharmacol Ther 12 (1998) 1011-1019
105. Evenepoel P., Geypens B., Luypaerts A., Hiele M., Ghoos Y., and Rutgeerts P. Digestibility of cooked and raw egg protein in humans as assessed by stable isotope techniques. J Nutr 128 (1998) 1716-1722
106. Mattison L.K., Ezzeldin H., Carpenter M., Modak A., Johnson M.R., and Diasio R.B. Rapid identification of dihydropyrimidine dehydrogenase deficiency by using a novel 2-13C-uracil breath test. Clin Cancer Res 10 (2004) 2652-2658
107. Kurpad A.V., Ajami A., and Young V.R. 13C breath tests in infections and beyond. Food Nutr Bull 23 3 Suppl. (2002) 21-29
108. Dominguez-Munoz J.E., Leodolter A., Sauerbruch T., and Malfertheiner P. A citric acid solution is an optimal test drink in the 13C-urea breath test for the diagnosis of Helicobacter pylori infection. Gut 40 (1997) 459-462
109. Graham D.Y., and Klein P.D. Accurate diagnosis of Helicobacter pylori. 13C-urea breath test. Gastroenterol Clin North Am 29 (2000) 885-893 x
110. Suto G., Vincze A., Pakodi F., Hunyady B., Karadi O., Garamszegi M., et al. 13C-Urea breath test is superior in sensitivity to detect Helicobacter pylori infection than either antral histology or rapid urease test. J Physiol Paris 94 (2000) 153-156
111. Bazzoli F., Cecchini L., Corvaglia L., Dall'Antonia M., De Giacomo C., Fossi S., et al. Validation of the 13C-urea breath test for the diagnosis of Helicobacter pylori infection in children: a multicenter study. Am J Gastroenterol 95 (2000) 646-650
112. Ellenrieder V., Glasbrenner B., Stoffels C., Weiler S., Bode G., Moller P., et al. Qualitative and semi-quantitative value of a modified 13C-urea breath test for identification of Helicobacter pylori infection. Eur J Gastroenterol Hepatol 9 (1997) 1085-1089
113. Pfaffenbach B., Wegener M., Adamek R.J., Wissuwa H., Schaffstein J., Aygen S., et al. Non-invasive 13C octanoic acid breath test for measuring stomach emptying of a solid test meal-correlation with scintigraphy in diabetic patients and reproducibility in healthy probands. Z Gastroenterol 33 (1995) 141-145
114. Ghoos Y.F., Maes B.D., Geypens B.J., Mys G., Hiele M.I., Rutgeerts P.J., et al. Measurement of gastric emptying rate of solids by means of a carbon-labeled octanoic acid breath test. Gastroenterology 104 (1993) 1640-1647
115. Barbosa L., Vera H., Moran S., Del Prado M., and Lopez-Alarcon M. Reproducibility and reliability of the 13C-acetate breath test to measure gastric emptying of liquid meal in infants. Nutrition 21 (2005) 289-294
116. Braden B., Peterknecht A., Piepho T., Schneider A., Caspary W.F., Hamscho N., et al. Measuring gastric emptying of semisolids in children using the 13C-acetate breath test: a validation study. Dig Liver Dis 36 (2004) 260-264
117. van Nieuwenhoven M.A., Wagenmakers A.J., Senden J.M., Brouns F., and Brummer R.J. Performance of the [13C]-acetate gastric emptying breath test during physical exercise. Eur J Clin Invest 29 (1999) 922-928
118. Mana F., Georges B., Reynaert H., Ham H.R., and Urbain D. Evaluation of the 13C-aminopyrine breath test using nondispersive infrared spectrometry. Acta Gastroenterol Belg 63 (2000) 328-330
119. Mion F., Geloen A., Rousseau M., Brazier J.L., and Minaire Y. Mechanism of carbon tetrachloride autoprotection: an in vivo study based on 13C-aminopyrine and 13C-galactose breath tests. Life Sci 54 (1994) 2093-2098
120. Candelli M., Armuzzi A., Nista E.C., Fini L., Gasbarrini G., and Gasbarrini A. 13C-methacetin breath test for monitoring hepatic function in cirrhotic patients before and after liver transplantation. Aliment Pharmacol Ther 19 (2004) 243
121. Petrolati A., Festi D., De Berardinis G., Colaiocco-Ferrante L., Di Paolo D., Tisone G., et al. 13C-methacetin breath test for monitoring hepatic function in cirrhotic patients before and after liver transplantation. Aliment Pharmacol Ther 18 (2003) 785-790
122. Zipprich A., Meiss F., Steudel N., Sziegoleit U., Fleig W.E., and Kleber G. 13C-Methacetin metabolism in patients with cirrhosis: relation to disease severity, haemoglobin content and oxygen supply. Aliment Pharmacol Ther 17 (2003) 1559-1562
123. Ciccocioppo R., Candelli M., Di Francesco D., Ciocca F., Taglieri G., Armuzzi A., et al. Study of liver function in healthy elderly subjects using the 13C-methacetin breath test. Aliment Pharmacol Ther 17 (2003) 271-277
124. Lara Baruque S., Razquin M., Jimenez I., Vazquez A., Gisbert J.P., and Pajares J.M. 13C-phenylalanine and 13C-methacetin breath test to evaluate functional capacity of hepatocyte in chronic liver disease. Dig Liver Dis 32 (2000) 226-232
125. Klatt S., Taut C., Mayer D., Adler G., and Beckh K. Evaluation of the 13C-methacetin breath test for quantitative liver function testing. Z Gastroenterol 35 (1997) 609-614
126. Matsumoto K., Suehiro M., Iio M., Kawabe T., Shiratori Y., Okano K., et al. [13C]methacetin breath test for evaluation of liver damage. Dig Dis Sci 32 (1987) 344-348
127. Saadeh S., Behrens P.W., Parsi M.A., Carey W.D., Connor J.T., Grealis M., et al. The utility of the 13C-galactose breath test as a measure of liver function. Aliment Pharmacol Ther 18 (2003) 995-1002
128. Koeda N., Iwai M., Kato A., and Suzuki K. Validity of 13C-phenylalanine breath test to evaluate functional capacity of hepatocyte in patients with liver cirrhosis and acute hepatitis. Aliment Pharmacol Ther 21 (2005) 851-859
129. Ishii Y., Suzuki S., Kohno T., Aoki M., Kohno T., Ito A., et al. L-[1-13C] phenylalanine breath test reflects histological changes in the liver. J Surg Res 114 (2003) 120-125
130. Tugtekin I., Wachter U., Barth E., Weidenbach H., Wagner D.A., Adler G., et al. Phenylalanine kinetics in healthy volunteers and liver cirrhotics: implications for the phenylalanine breath test. Am J Physiol Endocrinol Metab 283 (2002) E1223-E1231
131. Kobayashi T., Kubota K., Imamura H., Hasegawa K., Inoue Y., Takayama T., et al. Hepatic phenylalanine metabolism measured by the [13C]phenylalanine breath test. Eur J Clin Invest 31 (2001) 356-361
132. Milazzo L., Menzaghi B., Massetto B., Sangaletti O., and Riva A. 13C-methionine breath test detects drug-related hepatic mitochondrial dysfunction in HIV-infected patients. J Acquir Immune Defic Syndr 41 (2006) 252-253
133. Milazzo L., Piazza M., Sangaletti O., Gatti N., Cappelletti A., Adorni F., et al. [13C]Methionine breath test: a novel method to detect antiretroviral drug-related mitochondrial toxicity. J Antimicrob Chemother 55 (2005) 84-89
134. Park G.J., Katelaris P.H., Jones D.B., Seow F., Lin B.P., Le Couteur D.G., et al. The C-caffeine breath test distinguishes significant fibrosis in chronic hepatitis B and reflects response to lamivudine therapy. Aliment Pharmacol Ther 22 (2005) 395-403
135. Park G.J., Katelaris P.H., Jones D.B., Seow F., Le Couteur D.G., and Ngu M.C. Validity of the 13C-caffeine breath test as a noninvasive, quantitative test of liver function. Hepatology 38 (2003) 1227-1236
136. Murphy J.L., Robinson E.N., Forrester T.E., Wootton S.A., and Jackson A.A. Gastrointestinal handling and metabolic disposal of 13C-labelled tripalmitin during rehabilitation from childhood malnutrition. Br J Nutr 85 (2001) 705-713
137. Amarri S., Harding M., Coward W.A., Evans T.J., and Weaver L.T. 13Carbon mixed triglyceride breath test and pancreatic enzyme supplementation in cystic fibrosis. Arch Dis Child 76 (1997) 349-351
138. Murphy J.L., Jones A., Brookes S., and Wootton S.A. The gastrointestinal handling and metabolism of [1-13C]palmitic acid in healthy women. Lipids 30 (1995) 291-298
139. Wutzke K.D., and Glasenapp B. The use of 13C-labelled glycosyl ureides for evaluation of orocaecal transit time. Eur J Clin Nutr 58 (2004) 568-572
140. Vonk R.J., Lin Y., Koetse H.A., Huang C., Zeng G., Elzinga H., et al. Lactose (mal)digestion evaluated by the 13C-lactose digestion test. Eur J Clin Invest 30 (2000) 140-146
141. 2 breath test. Scand J Gastroenterol 34 (1999) 35-40
142. King C.E., and Toskes P.P. Breath tests in the diagnosis of small intestine bacterial overgrowth. Crit Rev Clin Lab Sci 21 (1984) 269-281